-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the prices of some Chinese medicinal materials have soared due to the shortage of market supply, the blind expansion of planting by medicinal farmers, and artificial increas.
Whether the price increase trend of Chinese medicinal materials will continue in the future has also attracted great attention from the socie.
The industry believes that with the continuous improvement of the quality requirements for Chinese medicinal materials, especially the implementation and advancement of the new version of the "Chinese Pharmacopoeia" standard, the price of Chinese medicinal materials may gradually become polarized due to different drug companies in the futu.
Compared with the old version, the new version of the Pharmacopoeia has established and improved the standard system of traditional Chinese medicine beverages, including comprehensively formulating the limit standards for heavy metals, harmful elements and pesticide residues in decoction pieces, and including them under the corresponding general rul.
For example, the limit standard for heavy metals and harmful elements in Chinese herbal medicines and decoction pieces (plants) stipulates that lead should not exceed 5mg/kg, cadmium should not exceed 1mg/kg, arsenic should not exceed 2mg/kg, mercury should not exceed 2mg/kg, and copper should not exceed 2mg/.
20mg/kg,e.
In the old version, only ginseng, licorice, astragalus and other varieties stipulated the limit standards for 9-22 kinds of organochlorine pesticide residues, while the new version of the pharmacopoeia for heavy metals and banned pesticides The general requirements for the plant medicinal materials included in the pharmacopoeia have reached the standa.
54 In terms of the detection standards of pesticide residues in traditional Chinese medicine, it is required that the multi-residue determination method of pesticides banned in medicinal materials and decoction pieces (plants) requires LC-MS/MS and GC-MS/MS as the main detection metho.
There are 33 kinds of pesticides detected, a total of 55 It is stipulated that all banned pesticides shall not be detected (the measured content is lower than the limit of quantification requirement of 01-1mg/K.
Among them, there are 31 compounds detected by LC-MS/MS method, 35 compounds detected by GC-MS/MS method, and 11 compounds can be detected by two methods at the same ti.
In addition, in the pesticide multi-residue determination method, the LC-MS method has set detection limits for 526 pesticides (including 3 internal standard compounds), an increase of nearly 370 pesticides, an increase of nearly 250%; the GC-MS method has increased to 153
In the past, the Chinese herbal medicines and decoction pieces were often shoddy, adulterated and counterfeit, and some herbal medicines had pesticide residues, heavy metals and harmful elements exceeding the standard, which seriously affected the quality and safety of Chinese herbal medicines, endangered public health, and hindered the Chinese herbal medicine indust.
And the healthy development of traditional Chinese medici.
The industry believes that the purpose of the implementation of the "Pharmacopoeia" is to make up for shortcomings, further improve the quality control level of listed drugs, and play an important role in enhancing the international influence of the Chinese Pharmacopoe.
Under the new policy, enterprises in the traditional Chinese medicine industry will enter the painful period of adapting to the new version of the Pharmacopoeia, facing many challenges such as stricter supervision, higher requirements, and increased testing costs, but in the long run, it will be conducive to the healthy development of the Chinese herbal medicine indust.
From the point of view of downstream enterprises, with the price increase of testing and other costs, Chinese medicinal materials may continue its price increase cyc.
"In the future, the scientific and standardized construction of Chinese herbal medicine bases, and large-scale management may become a major trend in the development of raw material producti.
" It is understood that in order to ensure stable supply of medicinal materials and controllable quality, many companies are currently building Chinese herbal medicine bases, such as Guizhou Baili.
It has built its own Chinese herbal medicine planting base for many yea.
As of the end of the reporting period in 2021, the company's planting area of traditional Chinese medicinal materials has exceeded 250,000 mu, covering 9 prefectures and cities in Guizhou Province, involving more than 20 varieties, and achieving an annual cultivation and propagation of 1 billion Chinese medicinal material seedlin.
Another example is Zhongzhi Pharmaceutical, Livzon Group, e.
, in order to ensure the quality of raw materials, they have also built their own GAP production bas.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
Whether the price increase trend of Chinese medicinal materials will continue in the future has also attracted great attention from the socie.
The industry believes that with the continuous improvement of the quality requirements for Chinese medicinal materials, especially the implementation and advancement of the new version of the "Chinese Pharmacopoeia" standard, the price of Chinese medicinal materials may gradually become polarized due to different drug companies in the futu.
Compared with the old version, the new version of the Pharmacopoeia has established and improved the standard system of traditional Chinese medicine beverages, including comprehensively formulating the limit standards for heavy metals, harmful elements and pesticide residues in decoction pieces, and including them under the corresponding general rul.
For example, the limit standard for heavy metals and harmful elements in Chinese herbal medicines and decoction pieces (plants) stipulates that lead should not exceed 5mg/kg, cadmium should not exceed 1mg/kg, arsenic should not exceed 2mg/kg, mercury should not exceed 2mg/kg, and copper should not exceed 2mg/.
20mg/kg,e.
In the old version, only ginseng, licorice, astragalus and other varieties stipulated the limit standards for 9-22 kinds of organochlorine pesticide residues, while the new version of the pharmacopoeia for heavy metals and banned pesticides The general requirements for the plant medicinal materials included in the pharmacopoeia have reached the standa.
54 In terms of the detection standards of pesticide residues in traditional Chinese medicine, it is required that the multi-residue determination method of pesticides banned in medicinal materials and decoction pieces (plants) requires LC-MS/MS and GC-MS/MS as the main detection metho.
There are 33 kinds of pesticides detected, a total of 55 It is stipulated that all banned pesticides shall not be detected (the measured content is lower than the limit of quantification requirement of 01-1mg/K.
Among them, there are 31 compounds detected by LC-MS/MS method, 35 compounds detected by GC-MS/MS method, and 11 compounds can be detected by two methods at the same ti.
In addition, in the pesticide multi-residue determination method, the LC-MS method has set detection limits for 526 pesticides (including 3 internal standard compounds), an increase of nearly 370 pesticides, an increase of nearly 250%; the GC-MS method has increased to 153
In the past, the Chinese herbal medicines and decoction pieces were often shoddy, adulterated and counterfeit, and some herbal medicines had pesticide residues, heavy metals and harmful elements exceeding the standard, which seriously affected the quality and safety of Chinese herbal medicines, endangered public health, and hindered the Chinese herbal medicine indust.
And the healthy development of traditional Chinese medici.
The industry believes that the purpose of the implementation of the "Pharmacopoeia" is to make up for shortcomings, further improve the quality control level of listed drugs, and play an important role in enhancing the international influence of the Chinese Pharmacopoe.
Under the new policy, enterprises in the traditional Chinese medicine industry will enter the painful period of adapting to the new version of the Pharmacopoeia, facing many challenges such as stricter supervision, higher requirements, and increased testing costs, but in the long run, it will be conducive to the healthy development of the Chinese herbal medicine indust.
From the point of view of downstream enterprises, with the price increase of testing and other costs, Chinese medicinal materials may continue its price increase cyc.
"In the future, the scientific and standardized construction of Chinese herbal medicine bases, and large-scale management may become a major trend in the development of raw material producti.
" It is understood that in order to ensure stable supply of medicinal materials and controllable quality, many companies are currently building Chinese herbal medicine bases, such as Guizhou Baili.
It has built its own Chinese herbal medicine planting base for many yea.
As of the end of the reporting period in 2021, the company's planting area of traditional Chinese medicinal materials has exceeded 250,000 mu, covering 9 prefectures and cities in Guizhou Province, involving more than 20 varieties, and achieving an annual cultivation and propagation of 1 billion Chinese medicinal material seedlin.
Another example is Zhongzhi Pharmaceutical, Livzon Group, e.
, in order to ensure the quality of raw materials, they have also built their own GAP production bas.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
